Economic evaluation of the treatment of type 2 diabetes with insulin glargine based on the LAPTOP trial

European Journal of Health Economics

Volumn 9, Issue 2, 2008, Pages 165-170

  Janka, Hans Uwe ^a   Högy, Barbara ^b  

^a Bremen North Hospital   (Germany)

^b SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Cost analysis; Insulin glargine; LAPTOP trial; Premixed insulin; Type 2 diabetes

Indexed keywords

GLIMEPIRIDE; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; METFORMIN; NEUTRAL INSULIN;

ARTICLE; BLOOD GLUCOSE MONITORING; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG UTILIZATION; ECONOMIC EVALUATION; HEALTH INSURANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; GERMANY; HEALTH CARE COSTS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; METFORMIN; NATIONAL HEALTH PROGRAMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SULFONYLUREA COMPOUNDS;

EID: 42149135625     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-007-0057-2     Document Type: Article

References (5)

1. Janka, H.U., Plewe, G., Riddle, M.C., Kliebe-Frisch, C., Schweitzer, M.A., Yki-Järvinen H.: Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes. Diabetes Care 28, 254-259 (2005)
2. Lauer-Taxe (official German price list for all registered drugs), Lauer-Fischer GmbH, Gebhardtstrasse 37-45, 90762 Fürth, www.lauer-fischer.de
3. Florian Müller GmbH-the friendly mail-order for diabetics, Wichmannstrasse 4, 22607 Hamburg, www.florian-mueller.de
4. Ypsomed GmbH, Otto-Volger Strasse 7c, 65843 Sulzbach/Taunus, www.ypsomed.de
5. Hoegy, B., Janka, H.U., Huppertz, E.: Economic evaluation of the LAPTOP-study results. Value Health 8(6), A 164 (2005)